All terms in GO
| Label | Id | Description |
|---|---|---|
| ciliary receptor clustering involved in smoothened signaling pathway | GO_0060830 | [Grouping of smoothened or patched receptors in a cilium, contributing to the smoothened signaling pathway.] |
| positive regulation of mast cell degranulation | GO_0043306 | [Any process that activates or increases the frequency, rate or extent of mast cell degranulation.] |
| lymphatic endothelial cell differentiation | GO_0060836 | [The process in which a venous blood vessel endothelial cell acquires specialized features of a lymphatic vessel endothelial cell, a thin flattened cell that lines the inside surfaces of lymph vessels.] |
| zonula adherens maintenance | GO_0045218 | [Maintaining the zonula adherens junction, the cell-cell adherens junction formed near the apex of epithelial cells.] |
| oral/aboral axis specification | GO_0060834 | [The establishment, maintenance and elaboration of a line that delineates the mouth and the anus of an embryo.] |
| transforming growth factor receptor beta signaling pathway involved in oral/aboral axis specification | GO_0060835 | [A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, which contributes to the specification of the oral/aboral axis.] |
| exit from host | GO_0035890 | [The directed movement of an organism out of the body, tissues or cells of the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.] |
| postsynaptic membrane | GO_0045211 | [A specialized area of membrane facing the presynaptic membrane on the tip of the nerve ending and separated from it by a minute cleft (the synaptic cleft). Neurotransmitters cross the synaptic cleft and transmit the signal to the postsynaptic membrane.] |
| neurotransmitter receptor biosynthetic process | GO_0045212 | [The chemical reactions and pathways resulting in the formation of neurotransmitter receptors.] |
| receptor metabolic process | GO_0043112 | [The chemical reactions and pathways involving a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.] |
| sarcomere organization | GO_0045214 | [The myofibril assembly process that results in the organization of muscle actomyosin into sarcomeres. The sarcomere is the repeating unit of a myofibril in a muscle cell, composed of an array of overlapping thick and thin filaments between two adjacent Z discs.] |
| GO_0045215 | GO_0045215 | |
| regulation of branching involved in mammary gland duct morphogenesis | GO_0060762 | [Any process that modulates the rate, frequency, or extent of branching involved in mammary gland duct morphogenesis.] |
| branching involved in mammary gland duct morphogenesis | GO_0060444 | [The process in which the branching structure of the mammary gland duct is generated and organized. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk.] |
| mammary duct terminal end bud growth | GO_0060763 | [The morphogenetic growth of the large, club-shaped terminal end of a mammary gland duct during prepubertal growth and during puberty.] |
| mammary gland duct morphogenesis | GO_0060603 | [The process in which anatomical structures of the mammary ducts are generated and organized. Mammary ducts are epithelial tubes that transport milk.] |
| positive regulation of response to cytokine stimulus | GO_0060760 | [Any process that increases the rate, frequency, or extent of a response to cytokine stimulus.] |
| regulation of response to cytokine stimulus | GO_0060759 | [Any process that modulates the rate, frequency, or extent of a response to cytokine stimulus.] |
| negative regulation of response to cytokine stimulus | GO_0060761 | [Any process that decreases the rate, frequency, or extent of a response to cytokine stimulus.] |
| negative regulation of androgen receptor signaling pathway | GO_0060766 | [Any process that decreases the rate, frequency, or extent of the androgen receptor signaling pathway.] |